Hansa Biopharma AB (publ) (STO: HNSA)
Sweden
· Delayed Price · Currency is SEK
55.20
+3.25 (6.26%)
Aug 30, 2024, 5:29 PM CET
Hansa Biopharma AB Employees
Hansa Biopharma AB had 168 employees as of December 31, 2023. The number of employees increased by 18 or 12.00% compared to the previous year.
Employees
168
Change (1Y)
18
Growth (1Y)
12.00%
Revenue / Employee
1.12M SEK
Profits / Employee
-5.49M SEK
Market Cap
3.74B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca PLC | 89,900 |
Swedish Orphan Biovitrum AB (publ) | 1,772 |
Getinge AB (publ) | 11,891 |
Sectra AB (publ) | 1,204 |
Camurus AB (publ) | 213 |
Medicover AB (publ) | 45,316 |
Elekta AB (publ) | 4,718 |
AddLife AB (publ) | 2,301 |
Hansa Biopharma AB News
- 9 days ago - Hansa Biopharma Announces Departure of Chief Commercial Officer, Matthew Shaulis - PRNewsWire
- 6 weeks ago - Hansa Biopharma Reports Second Quarter 2024 Financial Results and Business Update - PRNewsWire
- 2 months ago - Hansa Biopharma to host Q2 2024 interim results conference call - PRNewsWire
- 2 months ago - Hansa Biopharma: increase in number of shares and votes - PRNewsWire
- 3 months ago - Hansa Biopharma Completes Randomization in Pivotal Phase 3 US ConfIdeS Trial - PRNewsWire
- 3 months ago - Hansa Biopharma to present data at 2024 American Transplant Congress annual meeting - PRNewsWire
- 4 months ago - Hansa Biopharma interim report January-March 2024 - PRNewsWire
- 5 months ago - Hansa Biopharma Expects Strong First Quarter 2024 Sales Performance - PRNewsWire